Flamel Technologies Announces Receipt of Milestone from GlaxoSmithKline

23-May-2006

Flamel Technologies announced that it has received a $1 million milestone from its collaborator, GlaxoSmithKline. The milestone payment was triggered by successful completion of activities relating to the manufacturing process for Coreg CR(TM) microparticles. Flamel and GSK completed a supply agreement in December, 2004 under which Flamel is responsible for manufacturing Coreg CR(TM) microparticles.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!